M
MedGenesis Therapeutix
MedGenesis Therapeutix Inc.
About MedGenesis Therapeutix
MedGenesis Therapeutix Inc. is a private Canadian biopharmaceutical holding company dedicated to the commercialization of innovative treatments for serious neurologic diseases, with a primary focus on Parkinson's disease. The company operates in the biopharmaceutical sector, targeting neurodegenerative disorders through cutting-edge research and development. MedGenesis serves patients suffering from severe neurological conditions, aiming to bring advanced therapeutic solutions to market. The business model revolves around developing and commercializing novel treatments, leveraging the expertise of its leadership team, including Dr. Erich Mohr, a renowned expert in neurodegenerative disorders. Revenue is generated through the successful commercialization of these treatments, potentially including partnerships, licensing agreements, and direct sales. MedGenesis is committed to advancing the development of Glial Cell Line Derived Neurotrophic Factor (GDNF), a naturally occurring protein that may regenerate dying brain cells in Parkinson's patients and potentially reverse their condition.
Source: Dealroom company dataNews
Open roles
MedGenesis Therapeutix in the Victoria ecosystem
The MedGenesis Therapeutix office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Michael J. Fox Foundation for Parkinson's Research- DVDeutsche Parkinson Vereinigung
Andreessen Horowitz
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about MedGenesis Therapeutix on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See MedGenesis Therapeutix on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.